Sanofi · 1 day ago
Research Associate I (contract)
Sanofi is seeking a Research Associate I for a 12-month contract within their Cell Culture Development department. The role involves optimizing upstream cell culture processes and contributing to technical reports while ensuring compliance with safety standards.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Require to be on site daily; Weekend work required occasionally
Plan and execute experiments to optimize upstream cell culture platform process at different scales (shake flasks, AMBR, 3L/10L bioreactors, etc.)
Perform upstream experiments and collaborate with other functional groups to speed Phase I pipeline projects
Contribute to technical reports, experimental protocols, and technical summaries for presentation internally and externally
Participate in the technology transfer of processes into manufacturing facilities
Ensure safety and environmental compliance are maintained in the workplace
Some weekend working may be required for this role
Qualification
Required
Bachelor or Master's degree in Chemical Engineering, Biochemical Engineering, Cell Biology, Biochemistry or a related discipline
Post-education experience <=3 years
Understanding of aseptic technique and principles of mammalian cell culture
Detailed in lab operations and quick learner for new technologies
Preferred
Experience in the operation of fed-batch and/or perfusion-based cell culture bioreactors
Knowledge of CMC
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Recent News
2026-01-14
Company data provided by crunchbase